Ovid Therapeutics Statistics
NASDAQ: OVIDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.35-0.015 (-0.64%)
Market open · Delayed 15 min · as of Oct 8, 2:26 PM ET
Ovid Therapeutics by the numbers
Ovid Therapeutics has a market capitalization of $458.0 million based on 195.30M shares outstanding. With trailing EPS of $-0.22, Ovid Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.1% below its 50-day average and 1.5% above its 200-day average.
Average daily trading volume is 1.58M shares, or about $3.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
OVID valuation vs. peer median
| Metric | OVID | Peer median | Difference |
|---|---|---|---|
| Market cap | $457.97M | $458.88M | -0% |
| Avg. volume | 1.58M | 641.14K | +146% |
Peer median across 8 companies: ASMB, CAPR, SPRY, KMDA, PRTA, RZLT, ARVN, CTNM.
Valuation
- Market cap
- $457.97M
- EPS (TTM)
- $-0.22
- Shares outstanding
- 195.30M
Price and trading
- Previous close
- 2.36
- Open
- 2.32
- Day range
- 2.29 – 2.36
- 52-week range
- 1.18 – 3.11
- 52-week change
- +41.32%
- Beta
- —
- Volume
- 566.85K
- Average volume
- 1.58M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 457.97M
- Forward Pe
- -6.06
- Eps
- -0.22
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.11
- Week52 Low
- 1.18
- Avg Volume
- 1.58M
- Shares Outstanding
- 195.30M
- Ma50
- 2.64
- Ma200
- 2.31
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -24.48%
- Pct From52w Low
- 98.73%